OTCQX:MRVFF - Post by User
Post by
cjdavid1on Nov 11, 2009 10:24pm
524 Views
Post# 16477948
Faster-growing revenue streams: Good news
Faster-growing revenue streams: Good newsAll imho,
I was a bit shocked to see a positive news release not pertaining to FDA. Looks like the German subsidiary is stepping up financing and trials of WF10. Good job. Also, the NR teased us with the possibility of an earlier-than-anticipated revenue stream from Oxoferin. The NR was vague on the terms of the Oxoferin deal, however, the existing distribution channels with Ranbaxy Laboratories will boost revenues perhaps in Q1 (and a swift departure of the short buzzards).
As to the idea of Nuvo starting a share buy-back: it's cheaper and easier for Covidien to convince Nuvo to do a reverse-split (1:10 was a good proportion given by a previous poster), * watch the buzzards flock back, and the short volume increase again *, then toss a low-ball bid for Nuvo. Anyways, that won't happen for quite awhile. Any civil and intelligent thoughts, discussions, or rebuttals are welcome.
Meanwhile, back at my HQ, I am look forward to the progress of these pipelines, and the trading opportunities ;) as the Enormous float will cause drastic price swings.
Awaiting the next 2 quarterly results.
GLTA